ClinicalTrials.gg
Drug

Nepafenac clinical trials

Also written Nevanac.

studies test it
47
open now
1
in phase 3
9
first study started
2005

How each study uses nepafenac is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the nepafenac studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
19 Aug 2005 · NEVANAC · NDA 021862 (FDA, Drugs@FDA)
European Union
11 Dec 2007 · Nevanac · EMEA/H/C/000818 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Nepafenac
11
nepafenac 0.1%
6
Nepafenac 0.3%
4
Nepafenac 0.1% eyedrops
3
Nepafenac 0.3% Oph Susp
3

Brand

Nevanac
15

Studies by the year they started

46 studies that test it; most in 2009 (7)

Studies that test nepafenac, by start year
YearStudies
20051
20063
20072
20083
20097
20102
20113
20121
20136
20141
20152
20163
20171
20184
20202
20211
20241
20251
20262

By phase

A phase 1/2 study counts in both.

Phase 2
7
Phase 3
9
Phase 4
22
No phase
9

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 13 · Other 34

Alcon Research (10) · University Hospital of Patras (2) · Frank A. Bucci, Jr., M.D. (2) · Instituto de Oftalmología Fundación Conde de Valenciana (1) · Muhammad Aamir Latif (1) · Ankara Yildirim Beyazıt University (1) · Pomeranian Medical University Szczecin (1) · Indonesia University (1)

Often tested with

Tested in the same studies.

Ketorolac (10) · Bromfenac (8) · Diclofenac (3) · Ketorolac Tromethamine (3) · Lubricant (1) · Triamcinolone (1) · Indomethacin (1) · Difluprednate (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses nepafenac is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 47

See all 47 studies that test nepafenac →

As the comparator · 2 — what is tested is compared with nepafenac

Codes

What other systems call nepafenac · ClinicalTrials.gg INT004269

  • MeSH (NLM) C414203nepafenacConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 0J9L7J6V8CNEPAFENACConfirmed FDA, NLM, Wikidata
  • RxNorm 298665Confirmed FDA, Wikidata
  • Wikidata Q684379nepafenacConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C66228NepafenacOne source FDA
  • DrugBank DB06802One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.